The Duke Translational Research Institute’s mission is to rapidly and effectively invent, develop, and test new drugs, diagnostics, and devices for human use. DTRI, headed by Dr. Bruce Sullenger, provides guidance from experienced leadership, critical resources, and infrastructure for academic translational researchers.

Collaborations between the 'bench' scientists and the clinical researchers of the Duke Clinical Research Institute will allow cross-analysis access to early phases of development to plan how to bring discoveries forward to be useful to patients.

DTRI Components

Technology Cores

Biomarker Sciences

The DTRI is an active contributor to the North Carolina Research Campus through the MURDOCK study.

DTRI Funding Opportunities

The DTRI provides funding opportunities in many areas of translational research.

• Translational Pilot Project Program
• Request for Applications: Voucher for Specialty Core Services
• Request for Applications: Biomarker Discovery for the MURDOCK study
• Request for Applications: Methods in Biostatistics and Informatics for the MURDOCK study